No FDA Nod for Second Nasal Naloxone in Opioid OverdoseNo FDA Nod for Second Nasal Naloxone in Opioid Overdose

The FDA has declined approval for an intranasal naloxone spray for the emergency treatment of opioid overdose. Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news